Last reviewed · How we verify
NCT04656054
Hemoglobin Level, Coagulopathy Profile and Electrolyte Balance
trial testing liposuction in Lipodystrophy in 20 participants. Completed in 20 February 2024.
15 December 2023
Quick facts
| Lead sponsor | Alaa Hassan M. Elhawary |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 1 November 2020 |
| Primary completion | 15 December 2023 |
| Estimated completion | 20 February 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- liposuction
Conditions studied
- Lipodystrophy — all drugs for Lipodystrophy →
- Obesity — all drugs for Obesity →
Sponsor
Alaa Hassan M. Elhawary
Who can join
Adults 25 to 45, female only, with Lipodystrophy or Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
What is Impact of Amount Versus Surface Area of Liposuction on Haematological Parameters, Coagulopathy Profile and Electrolyte Balance? Liposuction involves the creation of extensive subsurface trauma, comparable in many respects to the massive injury of an internal burn. Liposuction commences with cannula aspiration of several liters of fluid-engorged adipose tissue, during which small feeder vessels are inevitably torn. Operating on multiple areas increases the area of injury regardless of whether just small amounts of fat are removed. Because many of the complications associated with large volume liposuction are related to fluid shifts and fluid balance, classifying the procedure based on the total volume removed from the patient, including fat, wetting solution, and blood, makes more sense to evaluate the damage made by the procedure. Safety and aesthetic issues define large-volume liposuction as having a 5,000-ml aspirate, mega-volume liposuction as having an 8,000-ml aspirate, and giganto-volume liposuction as having an aspirate of 12,000 ml or more.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04656054
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of liposuction
Trials testing the same drug.
- NCT04966078 — Treatment of Mild and Moderate Cases of Gynaecomastia · NA · unknown
Other recruiting trials for Lipodystrophy
Currently open trials in the same condition.
- NCT05996536 — Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD) · recruiting
- NCT06236932 — Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE" · NA · recruiting
- NCT05789251 — Assess the Possibility of Diagnosing Diabetes and Rediabetes Following Oral Induced Hyperglycemia in Patients With Dunni · NA · recruiting
- NCT05419037 — Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy · recruiting
- NCT02262806 — Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy · Phase 2 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04656054 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Alaa Hassan M. Elhawary
- Last refreshed: 1 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04656054.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing